FDA Home Page | CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER
Gleevec (Imatinib Mesylate)
Gleevec is approved to treat a rare cancer called Chronic Myeloid Leukemia (CML),
Back to Top Back to Drug Index
PDF requires the free Adobe Acrobat Reader
Date created: January 20, 2004; Updated February 26, 2007
CDER Home Page | CDER Site Info | Contact CDER | What's New @ CDER FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA | Privacy | Accessibility | HHS Home Page
FDA/Center for Drug Evaluation and Research